The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

American Cyanamid Company was a U.S.-based diversified company with businesses in several fields. The company was a manufacturer of agricultural chemicals, cosmetics, perfumes, building products, plastics and pharmaceuticals. The company was listed as a top 100 manufacturing company by Fortune magazine in the 1970s. Cyanamid was founded in 1907 and employed over 100,000 people around the world by 2000. The company maintained a monopoly over tetracycline, an antibiotic used against bacterial infections. A theft of the organism led to the loss of the monopoly as rival companies were able to produce generic versions of the formula, leading to huge losses to the company. The company sold most of its businesses in the early 2000s and is now operated under the name Cytec.  

Evans Cooling Systems, Inc. is a private company headquartered in the United States. The firm manufactures non-aqueous engine coolant products.

Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis, focal segmental glomerulosclerosis, and Dry Eye Syndrome.

Part of Dow, Inc., Equipolymers GmbH is a German company located in Schkopau that manufactures and markets PET resins. Thomas Serbe is currently the CEO of the firm.\nThe company says this about itself: Equipolymers is a company dedicated to the manufacture and marketing of PET resins. The company is a fully owned subsidiary of MEGlobal. smallworld.jpg Equipolymers is the preferred partner for brand-owners and other key value chain players in the PET market, through innovation-driven leadership and high-quality product standards. Equipolymers' production facilities are located in Schkopau (Germany).

Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.

Aquilus Pharmaceuticals is a privately held biotechnology company specializing in the treatment and management of pain. Aquilus Pharmaceuticals has been developing a series of proprietary MMP inhibitors and testing them in various pain models with the ultimate goal of producing a safe and effective drug for treating patients suffering from chronic pain. They know that their goal of developing a pain drug may take some time and be fraught with great uncertainty. However, they believe that the science that supports their mission is sound and their cause is important. As the famous French writer, Andre Gide, once wrote “man cannot discover new oceans unless he has the courage to lose sight of the shore.” Aquilus Pharmaceuticals is on a voyage of discovery and hopes that it will return from that voyage with the reward of a new drug for treating chronic pain.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.

Eyegene, Inc. engages in the research and development of pharmaceutical products. Its products include curing technologies and vaccines for diabetic retinopathy, decubitus ulcer, cervical cancer, and adjuvant immunotherapy. The company was founded on June 23, 2000 and is headquartered in Seoul, South Korea.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combine the company’s proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. The company’s research and development activities focus on infectious diseases and cardiometabolic disorders, while partnerships with major pharmaceutical companies include a range of therapeutic areas including cancer, cardiovascular disease, infectious and inflammatory diseases, and rare genetic disorders. The company has strategic partnerships with miRagen Therapeutics, Shire PLC, Pfizer, GlaxoSmithKline, and Enzon Pharmaceuticals. As part of its broad patent estate, the company holds exclusive worldwide rights to manufacture, have manufactured and sell products that contain LNA as an active ingredient for studies performed with a view to obtaining marketing approval. Santaris Pharma A/S, founded in 2003, is headquartered in Denmark with operations in the United States.

Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Bharat Serums And Vaccines Limited is one of the fastest growing bio pharmaceutical companies in India.BSV established in 1971 by the late Dr. Vinod Daftary researches, develops, manufactures, and markets injectable biological, pharmaceutical, and biotechnology products. derivatives, monoclonals, fertility hormones, antifungals, anaesthetics, cardiovascular drugs, and equine immunoglobulin /antitoxins.The R & D of drug delivery systems, biotechnology / recombinant therapeutics, and biological / equine products; assisted reproductive technology, critical care, emergency medicine, neurology, nephrology, haematology, and urology.The company provides its products to retail outlets and hospitals through distributors primarily in India, as well as in the Asia Pacific, the Russian Federation, CIS countries, Latin America, Africa, and internationally.BSV is amongst the top 10 Biotech companies in India. The company has in its portfolio over 25 brands.The company has over 750 employees selling its products across the country.Their brands are marketed all over India and exported to over 45 countries across the world They have an open and entrepreneurial culture, with each of their employees taking on significant responsibility in each activity of their value chain, be it in terms of research & development, manufacturing, quality, sales & marketing, distribution, business development or organization building.So if you are someone who is looking for a robust learning curve and enjoys taking responsibilities, you have landed on the right company page.